Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
15.79
-1.52 (-8.78%)
At close: Apr 1, 2025, 4:00 PM
16.00
+0.21 (1.32%)
After-hours: Apr 1, 2025, 5:31 PM EDT

Structure Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
169.51129.7926.09105.3116.35
Short-Term Investments
714.01337.5364.75221.09
Cash & Short-Term Investments
883.52467.3290.84107.3137.45
Cash Growth
89.06%414.44%-15.35%186.57%-
Prepaid Expenses
7.696.292.251.940.97
Total Current Assets
891.21473.6193.09109.2538.42
Property, Plant & Equipment
7.018.361.291.790.28
Long-Term Deferred Charges
--3.40.1-
Other Long-Term Assets
5.110.050.060.010.01
Total Assets
903.33482.0297.85111.1638.7
Accounts Payable
8.024.746.013.481.53
Accrued Expenses
26.318.566.574.591.23
Current Portion of Leases
1.71.440.260.350.15
Current Income Taxes Payable
--0.170.230.14
Total Current Liabilities
36.0224.7413.018.663.04
Long-Term Leases
2.164.01-0.270.13
Other Long-Term Liabilities
0.30.3---
Total Liabilities
38.4929.0513.018.933.17
Common Stock
0.020.01000
Additional Paid-In Capital
1,1936591.92-0.48
Retained Earnings
-329.1-206.57-116.95-64.74-22.95
Comprehensive Income & Other
0.910.52-0.11--0
Total Common Equity
864.84452.97-115.14-64.74-22.47
Shareholders' Equity
864.84452.9784.84102.2335.53
Total Liabilities & Equity
903.33482.0297.85111.1638.7
Total Debt
3.865.450.260.620.28
Net Cash (Debt)
879.66461.8790.58106.6937.17
Net Cash Growth
90.45%409.90%-15.10%187.06%-
Net Cash Per Share
16.7112.5728.3539.3117.81
Filing Date Shares Outstanding
57.3446.638.243.633.62
Total Common Shares Outstanding
57.2946.413.513.633.62
Working Capital
855.19448.8780.08100.5935.38
Book Value Per Share
15.109.76-32.81-17.83-6.20
Tangible Book Value
864.84452.97-115.14-64.74-22.47
Tangible Book Value Per Share
15.109.76-32.81-17.83-6.20
Machinery
3.752.511.271.150.02
Leasehold Improvements
1.361.360.110.11-
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q